These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21147548)
1. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548 [TBL] [Abstract][Full Text] [Related]
2. Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols. Paluszczak J; Krajka-Kuźniak V; Małecka Z; Jarmuż M; Kostrzewska-Poczekaj M; Grenman R; Baer-Dubowska W Toxicol In Vitro; 2011 Feb; 25(1):213-21. PubMed ID: 21078381 [TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer]. Zhang S; Kong WJ Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas. Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T Virchows Arch; 2008 Apr; 452(4):377-82. PubMed ID: 18299890 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000 [TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
7. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394 [TBL] [Abstract][Full Text] [Related]
8. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T Pathol Int; 2008 Aug; 58(8):477-82. PubMed ID: 18705766 [TBL] [Abstract][Full Text] [Related]
9. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197 [TBL] [Abstract][Full Text] [Related]
10. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma]. Yin D; Dong M Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861 [TBL] [Abstract][Full Text] [Related]
12. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Kulkarni V; Saranath D Oral Oncol; 2004 Feb; 40(2):145-53. PubMed ID: 14693237 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590 [TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients. Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521 [TBL] [Abstract][Full Text] [Related]
18. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Gutiérrez MI; Siraj AK; Khaled H; Koon N; El-Rifai W; Bhatia K Mod Pathol; 2004 Oct; 17(10):1268-74. PubMed ID: 15154012 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119 [TBL] [Abstract][Full Text] [Related]
20. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]